Organigram Global (OGI) Cash from Operations (2018 - 2026)
Organigram Global (OGI) posted quarterly Cash from Operations of 16606201.22 for Q1 2026, down 43.67% year-on-year from 29481592.61 in Q1 2025, and down 44.62% on a QoQ basis from 11482702.65 in Q4 2025.
Organigram Global (OGI) Cash from Operations (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Cash from Operations for 7 consecutive years, with 16606201.22 the latest figure, recorded in Q1 2026.
- Quarterly Cash from Operations fell 43.67% year-over-year to 16606201.22 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 42639513.04 (up 99.9% YoY) and the FY2025 annual result came in at 5515886.31, down 294.33% from the prior year.
- Cash from Operations declined to 16606201.22 in Q1 2026 per OGI's latest filing, from 11482702.65 in the prior quarter.
- Over the last five years, Cash from Operations for OGI reached as high as 2992249.41 in Q4 2024 and fell as low as 16606201.22 in Q1 2026.
- A 3-year average of 10659878.26 and a median of 11520531.2 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2025 — Cash from Operations slumped 283.75% — and 2026, when it sank 43.67%.
- Year by year, Cash from Operations stood at 2992249.41 in 2024, then sank by 283.75% to 11482702.65 in 2025, then sank by 44.62% to 16606201.22 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 16606201.22, 11482702.65, and 11558359.76 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | -16.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.61 Mn |
| Mar 31, 2026 | -16.61 Mn |
| Dec 31, 2025 | -11.48 Mn |
| Dec 31, 2025 | -11.48 Mn |
| Mar 31, 2025 | -11.56 Mn |
| Mar 31, 2025 | -11.56 Mn |
| Dec 31, 2024 | -2.99 Mn |
| Dec 31, 2024 | -2.99 Mn |
| May 31, 2021 | -20.89 Mn |
| May 31, 2021 | -20.89 Mn |
| Feb 28, 2021 | -42.78 Bn |
| Feb 28, 2021 | -42.78 Bn |
| Nov 30, 2020 | 79.30 Bn |
| Nov 30, 2020 | 79.30 Bn |
| Aug 31, 2020 | -21.32 Mn |
| Aug 31, 2020 | -21.32 Mn |
| May 31, 2020 | 8.54 Bn |
| May 31, 2020 | 8.54 Bn |
| Feb 29, 2020 | 25,011.00 |
| Feb 29, 2020 | 25,011.00 |